{"id":1016485,"date":"2026-11-02T21:00:02","date_gmt":"2026-11-03T02:00:02","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/ibio-to-participate-in-upcoming-investor-conferences-2\/"},"modified":"2026-11-02T21:00:02","modified_gmt":"2026-11-03T02:00:02","slug":"ibio-to-participate-in-upcoming-investor-conferences-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ibio-to-participate-in-upcoming-investor-conferences-2\/","title":{"rendered":"iBio to Participate in Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">SAN DIEGO, Nov.  02, 2026  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HJyo48PsViYqJSFUjAZBHUhxbt-XBWloqd6ojd6RLyQcVBbjcbm9m9ICKO4L0T2NXvB5RLEiyyrWsUv2Z_Ywsg==\" rel=\"nofollow\" target=\"_blank\">iBio, Inc.<\/a><strong> (NASDAQ: IBIO),<\/strong> a clinical-stage biotechnology company developing long-acting antibody therapeutics for obesity, cardiometabolic and cardiopulmonary diseases, today announced that Martin Brenner, DVM, Ph.D., Chief Executive Officer and Chief Scientific Officer, and Felipe Duran, Chief Financial Officer, will participate in the following investor conferences in November and December 2026.<\/p>\n<p>\n        <strong><br \/>\n          <u>Guggenheim Healthcare Innovation 2026 Conference<\/u><br \/>\n        <\/strong><br \/>\n        <br \/>\n        <strong>When: <\/strong>November 9 &#8211; 11\u00a0 <br \/><strong>Format:<\/strong> Fireside chat<br \/><strong>Date &amp; Time:<\/strong> November 10, 2026: 9:00 a.m. ET <br \/><strong>Location:<\/strong> Boston<\/p>\n<p align=\"justify\">A livestream of the event can be accessed <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ay4LWzyTNPhErLIDtlGhwlMEIsx5ZCAZN0zzCDqL4LP0ZZBXQk_YKebKIdxbdIvbyHyQhSGXfClY1y6MjK61bjZEl_MzR0I4RTnrjAEsTNF1WcpWxLEDnGli8Rty32_grstrSVhpBfzV4Fz2wtjRCQ==\" rel=\"nofollow\" target=\"_blank\">here<\/a>.<\/p>\n<p>\n        <strong><br \/>\n          <u>Jefferies Global Healthcare Conference<\/u><br \/>\n        <\/strong><br \/>\n        <br \/>\n        <strong>When: <\/strong>November 16 &#8211; 19\u00a0 <br \/><strong>Format:<\/strong> 1:1 Meetings<br \/><strong>Location: <\/strong>The Waldorf Hilton, London<\/p>\n<p>\n        <strong><br \/>\n          <u>Piper Sandler 38<sup>th<\/sup> Annual Healthcare Conference<\/u><br \/>\n        <\/strong><br \/>\n        <br \/>\n        <strong>Dates: <\/strong>December 1 &#8211; 3 <br \/><strong>Format: <\/strong>Fireside Chat<br \/><strong>Date &amp; Time<\/strong>: December 1, 9:30-9:55 a.m. ET<br \/><strong>Presenters:<\/strong> Martin Brenner, Felipe Duran<br \/><strong>Location: <\/strong>Lotte New York Palace, New York City<\/p>\n<p>A livestream of the event can be accessed from the events page of the iBio website.<\/p>\n<p>Dr. Brenner and Mr. Duran will be available for one-on-one meetings during each conference. A link to access each of the replays and presentations will be available on the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Dgbs7mF7DvpVLQgiZ2JodtqNshF6_qAKYr520n-4tRP9_8WLVWKP__B0gnWI0M7ikZVjylSrPmXf63J2ocMFrb0ge1jMWClFRgKkzSehAqE=\" rel=\"nofollow\" target=\"_blank\">Investor section<\/a> of the iBio website for 90 days after the event.<\/p>\n<p align=\"justify\">\n        <strong>About iBio, Inc.<\/strong>\n      <\/p>\n<p align=\"justify\">iBio (Nasdaq: IBIO) is a clinical-stage biotechnology developing long-acting antibody therapeutics for obesity, cardiometabolic and cardiopulmonary diseases, cancer, and other hard-to-treat diseases. Combining advanced antibody engineering with AI-driven discovery, iBio is advancing a differentiated pipeline designed to deliver sustained therapeutic effects and address significant unmet medical needs. iBio&#8217;s mission is to transform drug discovery, accelerate development timelines, and unlock new possibilities in precision medicine.<\/p>\n<p align=\"justify\">For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=tw_SCVgmeq0guGqQB7GBuMGvj0OAiB-oEtuFSZw1cKDVW5BdWLBqcrOMoC8XLc6KOTPYnDodvqx1dtAzU2mi40nA5SJXB4KKBXkM2hgbRxY=\" rel=\"nofollow\" target=\"_blank\">www.ibioinc.com<\/a> or follow us on LinkedIn.<\/p>\n<p>\n        <strong>Investor Contact<\/strong><br \/>\n        <br \/>Matt Beck<br \/>astr partners<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=16HbC7Jzms_dmpeiEO7U9M_IPqO4hZIgigv_7_goyvfJBiKhFYKFm7AzAk4cDQ6tAadfA3cvpc4_9JuqHWv8-BaFF4EFAHW7o8GdOkXnmyhtngZ2OQytjRtrNYzYBU43\" rel=\"nofollow\" target=\"_blank\">matthew.beck@astrpartners.com<\/a><br \/>(917) 415-1750<\/p>\n<p>\n        <strong>Media Contact<\/strong><br \/>\n        <br \/>Jason Braco, Ph.D.<br \/>Valence Communications<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=sQChwkeM9t_c5haCq_WbM6NfweuEAJSYholfbqe6A9t1S1VIYL7R4Mw-R96Toagr_NgdSyjRpkU2PrgrrPfmF2WCukjIcEdx-DrYRpB3jiQ=\" rel=\"nofollow\" target=\"_blank\">jason@valencecomms.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg2ODM3NiM3OTQwNTg4IzIwODc1NzM=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZmU0ZDAyMjYtZjM0NS00YjIyLTk4NGItYTI1MTc5MTdlMTVmLTEwOTkxNDQtMjAyNi0xMS0wMi1lbg==\/tiny\/iBio-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO, Nov. 02, 2026 (GLOBE NEWSWIRE) &#8212; iBio, Inc. (NASDAQ: IBIO), a clinical-stage biotechnology company developing long-acting antibody therapeutics for obesity, cardiometabolic and cardiopulmonary diseases, today announced that Martin Brenner, DVM, Ph.D., Chief Executive Officer and Chief Scientific Officer, and Felipe Duran, Chief Financial Officer, will participate in the following investor conferences in November and December 2026. Guggenheim Healthcare Innovation 2026 Conference When: November 9 &#8211; 11\u00a0 Format: Fireside chatDate &amp; Time: November 10, 2026: 9:00 a.m. ET Location: Boston A livestream of the event can be accessed here. Jefferies Global Healthcare Conference When: November 16 &#8211; 19\u00a0 Format: 1:1 MeetingsLocation: The Waldorf Hilton, London Piper Sandler 38th Annual Healthcare Conference Dates: December 1 &#8211; 3 Format: Fireside ChatDate &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ibio-to-participate-in-upcoming-investor-conferences-2\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;iBio to Participate in Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1016485","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>iBio to Participate in Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ibio-to-participate-in-upcoming-investor-conferences-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"iBio to Participate in Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, Nov. 02, 2026 (GLOBE NEWSWIRE) &#8212; iBio, Inc. (NASDAQ: IBIO), a clinical-stage biotechnology company developing long-acting antibody therapeutics for obesity, cardiometabolic and cardiopulmonary diseases, today announced that Martin Brenner, DVM, Ph.D., Chief Executive Officer and Chief Scientific Officer, and Felipe Duran, Chief Financial Officer, will participate in the following investor conferences in November and December 2026. Guggenheim Healthcare Innovation 2026 Conference When: November 9 &#8211; 11\u00a0 Format: Fireside chatDate &amp; Time: November 10, 2026: 9:00 a.m. ET Location: Boston A livestream of the event can be accessed here. Jefferies Global Healthcare Conference When: November 16 &#8211; 19\u00a0 Format: 1:1 MeetingsLocation: The Waldorf Hilton, London Piper Sandler 38th Annual Healthcare Conference Dates: December 1 &#8211; 3 Format: Fireside ChatDate &hellip; Continue reading &quot;iBio to Participate in Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ibio-to-participate-in-upcoming-investor-conferences-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-03T02:00:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg2ODM3NiM3OTQwNTg4IzIwODc1NzM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ibio-to-participate-in-upcoming-investor-conferences-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ibio-to-participate-in-upcoming-investor-conferences-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"iBio to Participate in Upcoming Investor Conferences\",\"datePublished\":\"2026-11-03T02:00:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ibio-to-participate-in-upcoming-investor-conferences-2\\\/\"},\"wordCount\":295,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ibio-to-participate-in-upcoming-investor-conferences-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg2ODM3NiM3OTQwNTg4IzIwODc1NzM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ibio-to-participate-in-upcoming-investor-conferences-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ibio-to-participate-in-upcoming-investor-conferences-2\\\/\",\"name\":\"iBio to Participate in Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ibio-to-participate-in-upcoming-investor-conferences-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ibio-to-participate-in-upcoming-investor-conferences-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg2ODM3NiM3OTQwNTg4IzIwODc1NzM=\",\"datePublished\":\"2026-11-03T02:00:02+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ibio-to-participate-in-upcoming-investor-conferences-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ibio-to-participate-in-upcoming-investor-conferences-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ibio-to-participate-in-upcoming-investor-conferences-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg2ODM3NiM3OTQwNTg4IzIwODc1NzM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg2ODM3NiM3OTQwNTg4IzIwODc1NzM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ibio-to-participate-in-upcoming-investor-conferences-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"iBio to Participate in Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"iBio to Participate in Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ibio-to-participate-in-upcoming-investor-conferences-2\/","og_locale":"en_US","og_type":"article","og_title":"iBio to Participate in Upcoming Investor Conferences - Market Newsdesk","og_description":"SAN DIEGO, Nov. 02, 2026 (GLOBE NEWSWIRE) &#8212; iBio, Inc. (NASDAQ: IBIO), a clinical-stage biotechnology company developing long-acting antibody therapeutics for obesity, cardiometabolic and cardiopulmonary diseases, today announced that Martin Brenner, DVM, Ph.D., Chief Executive Officer and Chief Scientific Officer, and Felipe Duran, Chief Financial Officer, will participate in the following investor conferences in November and December 2026. Guggenheim Healthcare Innovation 2026 Conference When: November 9 &#8211; 11\u00a0 Format: Fireside chatDate &amp; Time: November 10, 2026: 9:00 a.m. ET Location: Boston A livestream of the event can be accessed here. Jefferies Global Healthcare Conference When: November 16 &#8211; 19\u00a0 Format: 1:1 MeetingsLocation: The Waldorf Hilton, London Piper Sandler 38th Annual Healthcare Conference Dates: December 1 &#8211; 3 Format: Fireside ChatDate &hellip; Continue reading \"iBio to Participate in Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ibio-to-participate-in-upcoming-investor-conferences-2\/","og_site_name":"Market Newsdesk","article_published_time":"2026-11-03T02:00:02+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg2ODM3NiM3OTQwNTg4IzIwODc1NzM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ibio-to-participate-in-upcoming-investor-conferences-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ibio-to-participate-in-upcoming-investor-conferences-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"iBio to Participate in Upcoming Investor Conferences","datePublished":"2026-11-03T02:00:02+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ibio-to-participate-in-upcoming-investor-conferences-2\/"},"wordCount":295,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ibio-to-participate-in-upcoming-investor-conferences-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg2ODM3NiM3OTQwNTg4IzIwODc1NzM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ibio-to-participate-in-upcoming-investor-conferences-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ibio-to-participate-in-upcoming-investor-conferences-2\/","name":"iBio to Participate in Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ibio-to-participate-in-upcoming-investor-conferences-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ibio-to-participate-in-upcoming-investor-conferences-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg2ODM3NiM3OTQwNTg4IzIwODc1NzM=","datePublished":"2026-11-03T02:00:02+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ibio-to-participate-in-upcoming-investor-conferences-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ibio-to-participate-in-upcoming-investor-conferences-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ibio-to-participate-in-upcoming-investor-conferences-2\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg2ODM3NiM3OTQwNTg4IzIwODc1NzM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg2ODM3NiM3OTQwNTg4IzIwODc1NzM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ibio-to-participate-in-upcoming-investor-conferences-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"iBio to Participate in Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1016485","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1016485"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1016485\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1016485"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1016485"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1016485"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}